Abstract
The aims of the current study were to investigate the influence of insufficient radiofrequency ablation (RFA) on the cell proliferation of the human hepatocellular carcinoma (HCC) cells, SMMC7721, and to elucidate the underlying mechanism. SMMC7721 cells were subjected to a 47°C treatment regimen to simulate insufficient RFA, in the presence or absence of KN93 [a specific inhibitor of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII)], PD98059 [a specific inhibitor of extracellular signal-regulated kinase (ERK)], or axitinib (a specific inhibitor of vascular endothelial growth factor (VEGF) receptor]. Cell proliferation was determined using a thiazolyl terazolium assay (MTT). The levels of CaMKII, phospho-CaMKII, ERK, phospho-ERK and VEGF were observed by western blot analysis. The results demonstrated that the 47°C treatment regimen: i) Triggered upregulation of VEGF expression in the SMMC7721 cells, which was reduced by CaMKII or ERK inhibition; ii) induced ERK activation was prevented by KN93; and iii) promoted SMMC7721 cell proliferation, which was greatly inhibited by axitinib, KN93 and PD98059. In conclusion, the results indicated that insufficient RFA promotes SMMC7721 cell proliferation by activating CaMKII/ERK-dep...Continue Reading
References
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
May 9, 2008·The New England Journal of Medicine·Robert S Kerbel
May 20, 2008·Surgical Oncology Clinics of North America·Richard BryantDaniel Cherqui
Dec 25, 2008·Annals of Surgery·Wan Yee Lau, Eric C H Lai
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Lars S Maier
Mar 1, 2008·Hepatology International·Koichi ObaraFumio Itoh
Nov 12, 2009·Endocrine-related Cancer·Maria Rosaria RuscianoMario Vitale
Jun 22, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Riccardo Lencioni
Dec 9, 2010·The Oncologist·Alan P VenookLaura Ladrón de Guevara
Sep 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ahmed O KasebJames L Abbruzzese
May 23, 2012·PloS One·Jian KongWen-bing Sun
Oct 12, 2013·International Journal of Cancer. Journal International Du Cancer·Matteo SantoniStefano Cascinu
Oct 31, 2013·Journal of Translational Medicine·Shuying DongLemin Zheng
Jan 23, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eleonora RussoMario Vitale
Feb 26, 2014·Annals of Surgical Oncology·Shinichiro YamadaMitsuo Shimada
May 14, 2014·International Journal of Molecular Medicine·Li XueYanjiong Chen
May 27, 2014·European Journal of Pharmacology·Kai ZhaoNa Lu
Aug 27, 2014·Alimentary Pharmacology & Therapeutics·K V MenonN D Heaton
Citations
Mar 19, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tetsuya IkemotoShinichiro Yamada
Feb 10, 2016·Scientific Reports·Yongjian LiuYinghui Xu
Jan 20, 2017·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Yang NiMin Meng
Aug 10, 2017·Oncology Letters·Hongliang DaiMinghui Chu
Mar 7, 2020·Biological Chemistry·Haicun WangWeihua Dui
Nov 8, 2018·Journal of Translational Medicine·Rui ZhangRong-Xin Chen
Aug 8, 2020·Frontiers in Bioengineering and Biotechnology·Qiongchao JiangBaoming Luo
Apr 3, 2019·Journal of Clinical Gastroenterology·Yuanjian HuangQichang Zheng
Nov 21, 2020·Medical Oncology·Guoqun JiaXiang Ji
Nov 5, 2020·BioMed Research International·Yongchuan ZhangHaitao Gu
Feb 20, 2018·Cancer Letters·Zizhuo ZhaoBaoming Luo
Jul 9, 2021·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Peng YanFengsheng Li